Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−5,563−100.0%Sold outHolders
Q1 20265,563$223.8K<0.1%−26,600−82.7%ReducedHolders
Q4 202532,163$807.9K<0.1%+13,660+73.8%AddedHolders
Q3 202518,503$418.7K<0.1%−789−4.1%ReducedHolders
Q2 202519,292$333.9K<0.1%−1,483,917−98.7%ReducedHolders
Q1 20251,503,209$32.9M<0.1%−624,456−29.3%ReducedHolders
Q4 20242,127,665$67.9M<0.1%−772,589−26.6%ReducedHolders
Q3 20242,900,254$83.6M<0.1%−399,536−12.1%ReducedHolders
Q2 20243,299,790$126.6M<0.1%+1,121,048+51.5%AddedHolders
Q1 20242,178,742$128.1M<0.1%+86,278+4.1%AddedHolders
Q4 20232,092,464$125.3M<0.1%−167,302−7.4%ReducedHolders
Q3 20232,259,766$86.0M<0.1%−1,965,829−46.5%ReducedHolders
Q2 20234,225,595$385.0M<0.1%+2,100,158+98.8%AddedHolders
Q1 20232,125,437$140.2M<0.1%+665,274+45.6%AddedHolders
Q4 20221,460,163$75.5M<0.1%−10.0%ReducedHolders
Q3 20221,460,164$99.7M<0.1%+71,737+5.2%AddedHolders
Q2 20221,388,427$62.8M<0.1%−9,165−0.7%ReducedHolders
Q1 20221,397,592$71.0M<0.1%−217,267−13.5%ReducedHolders
Q4 20211,614,859$76.4M<0.1%00.0%UnchangedHolders
Q3 20211,614,859$53.2M<0.1%+143,694+9.8%AddedHolders
Q2 20211,471,165$93.0M<0.1%−150,087−9.3%ReducedHolders
Q1 20211,621,252$69.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.